Case report: Alectinib-associated intestinal ulceration and colitis in a patient with non-small cell lung cancer and effective treatment with Mesalazine

Case report: Alectinib-associated intestinal ulceration and colitis in a patient with non-small cell lung cancer and effective treatment with Mesalazine

BackgroundAlectinib is effective in extending the survival of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and generally has manageable side effects. However, intestinal ulcers and colitis are rare but serious adverse reactions linked to Alectinib, merit...

Full description

Saved in:
Bibliographic Details
Main Authors: Zijian Qiu, Fei Ke, Xiaoping Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Pathology and Oncology Research
Subjects:
Alectinib
intestinal ulcer
colitis
anaplastic lymphoma kinase inhibitor
non-small cell lung cancer
Online Access:https://www.por-journal.com/articles/10.3389/pore.2025.1612040/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items